Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on February 28, 2024, reporting events occurring on February 27, 2024. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is a significant leadership transition effective February 27, 2024:
- Resignation: Kenneth L. Londoner resigned from all positions, including Director, Executive Chairman, and Chief Executive Officer.
- Appointment: Frederick D. Hrkac, a former director, was appointed as Director, President, and Principal Executive Officer.
- Reasoning: The filing explicitly states that Mr. Londoner's resignation was not the result of any disagreement regarding the Company's operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks, contingencies, or unusual items were disclosed in this report. The document confirms there are no undisclosed transactions involving Mr. Hrkac requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the new leadership structure and the background of Frederick D. Hrkac.
- Confirm the status of the company's strategic direction following the departure of the former CEO and Chairman.
- Review subsequent filings for any financial updates or strategic shifts resulting from this management change.